Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,842 | 481 | 99.8% |
| Education | $13.60 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,088 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,078 | 70 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,073 | 74 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $533.66 | 44 | $0 (2023) |
| Lilly USA, LLC | $381.92 | 29 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $380.64 | 31 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $345.92 | 21 | $0 (2023) |
| ABBVIE INC. | $292.28 | 17 | $0 (2024) |
| Amgen Inc. | $290.27 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $271.05 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.25 | 15 | AstraZeneca Pharmaceuticals LP ($100.15) |
| 2023 | $732.34 | 46 | Janssen Pharmaceuticals, Inc ($162.65) |
| 2022 | $1,122 | 70 | Novo Nordisk Inc ($186.44) |
| 2021 | $898.14 | 63 | SANOFI-AVENTIS U.S. LLC ($140.14) |
| 2020 | $745.13 | 58 | Novo Nordisk Inc ($177.52) |
| 2019 | $980.25 | 71 | Novo Nordisk Inc ($318.98) |
| 2018 | $1,074 | 82 | AstraZeneca Pharmaceuticals LP ($218.77) |
| 2017 | $1,048 | 77 | AstraZeneca Pharmaceuticals LP ($254.68) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Bone Health | ||||||
| 03/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Bone Health | ||||||
| 11/27/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Respiratory | ||||||
| 10/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: DEVICE | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,410 | 8,875 | $511,021 | $226,318 |
| 2022 | 42 | 5,396 | 8,741 | $518,701 | $238,178 |
| 2021 | 37 | 5,350 | 8,896 | $536,651 | $273,390 |
| 2020 | 46 | 7,354 | 11,358 | $687,172 | $267,064 |
All Medicare Procedures & Services
166 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 613 | 1,543 | $192,875 | $108,595 | 56.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 226 | 226 | $31,640 | $27,122 | 85.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 126 | $22,585 | $13,757 | 60.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 536 | 767 | $39,884 | $9,901 | 24.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 568 | 907 | $53,513 | $9,288 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 595 | 1,097 | $8,776 | $8,453 | 96.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 427 | 508 | $32,004 | $8,279 | 25.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 568 | 935 | $24,310 | $5,854 | 24.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 282 | 467 | $19,147 | $4,370 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 53 | $4,558 | $2,967 | 65.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 154 | 154 | $3,542 | $2,576 | 72.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 51 | 62 | $11,594 | $2,406 | 20.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $2,560 | $2,311 | 90.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 81 | 98 | $8,428 | $1,943 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 72 | $1,656 | $1,623 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 73 | 73 | $1,971 | $1,577 | 80.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 35 | 38 | $3,420 | $1,541 | 45.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 42 | 50 | $5,900 | $1,421 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $2,898 | $1,393 | 48.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 98 | 153 | $5,355 | $1,352 | 25.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 50 | 50 | $3,150 | $946.00 | 30.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 28 | 58 | $2,378 | $908.32 | 38.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 26 | 26 | $2,340 | $865.50 | 37.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 121 | 123 | $3,075 | $741.96 | 24.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 20 | $2,200 | $728.46 | 33.1% |
About Dr. John Stanback, MD
Dr. John Stanback, MD is a Family Medicine healthcare provider based in Columbus, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629034764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Stanback, MD has received a total of $6,856 in payments from pharmaceutical and medical device companies, with $255.25 received in 2024. These payments were reported across 482 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,842).
As a Medicare-enrolled provider, Stanback has provided services to 23,510 Medicare beneficiaries, totaling 37,870 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Columbus, MS
- Active Since 04/26/2006
- Last Updated 05/14/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629034764
Products in Payments
- FARXIGA (Drug) $657.54
- Ozempic (Drug) $569.02
- SOLIQUA 100/33 (Biological) $537.00
- JARDIANCE (Drug) $510.32
- XARELTO (Drug) $323.86
- BREZTRI (Drug) $309.41
- TOUJEO (Drug) $284.94
- Kerendia (Drug) $271.05
- UBRELVY (Drug) $213.21
- JANUVIA (Drug) $204.89
- Rybelsus (Drug) $188.52
- EVENITY (Biological) $174.07
- TRULICITY (Drug) $173.47
- Victoza (Drug) $160.05
- ENTRESTO (Drug) $154.89
- Tresiba (Drug) $146.36
- SOLIQUA (Drug) $134.35
- ELIQUIS (Drug) $120.38
- EMGALITY (Drug) $113.99
- NEXLETOL (Drug) $95.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Brian Beesley, Do, DO
Family Medicine — Payments: $1.5M
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168